International Clinical Trial: A Clinical Study on Identifying High-Risk Postoperative Recurrence Population of Stage I EGFR-Mutated Lung Cancer Based on Multimodal Indicators and Early Intervention with Third-Generation TKIs

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133476) titled 'A Clinical Study on Identifying High-Risk Postoperative Recurrence Population of Stage I EGFR-Mutated Lung Cancer Based on Multimodal Indicators and Early Intervention with Third-Generation TKIs' on Sept. 28.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shanghai General Hospital

Condition: lung cancer

Intervention: Third-generation EGFR-TKI first-line treatment:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-28

Target Sample Size: Third-generation EGFR-TKI first-line treatment:50;Regular check-up:50;

Countries of Recruitment: China...